Kanje Livin E, Kumburu Happiness, Kuchaka Davis, Shayo Mariana, Juma Masoud A, Kimu Patrick, Beti Melkiory, van Zwetselaar Marco, Wadugu Boaz, Mmbaga Blandina T, Mkumbaye Sixbert Isdory, Sonda Tolbert
Department of Microbiology and Immunology, Kilimanjaro Christian Medical University College, Kilimanjaro, Tanzania.
Kilimanjaro Clinical Research Institute, Kilimanjaro, Tanzania.
BMC Med Genomics. 2024 Apr 26;17(1):110. doi: 10.1186/s12920-024-01882-y.
Escherichia coli is known to cause about 2 million deaths annually of which diarrhea infection is leading and typically occurs in children under 5 years old. Although Africa is the most affected region there is little information on their pathotypes diversity and their antimicrobial resistance.
To determine the pathotype diversity and antimicrobial resistance among E. coli from patients attending regional referral hospitals in Tanzania.
A retrospective cross-section laboratory-based study where a total of 138 archived E. coli isolates collected from 2020 to 2021 from selected regional referral hospitals in Tanzania were sequenced using the Illumina Nextseq550 sequencer platform. Analysis of the sequences was done in the CGE tool for the identification of resistance genes and virulence genes. SPSS version 20 was used to summarize data using frequency and proportion.
Among all 138 sequenced E. coli isolates, the most prevalent observed pathotype virulence genes were of extraintestinal E. coli UPEC fyuA gene 82.6% (114/138) and NMEC irp gene 81.9% (113/138). Most of the E. coli pathotypes observed exist as a hybrid due to gene overlapping, the most prevalent pathotypes observed were NMEC/UPEC hybrid 29.7% (41/138), NMEC/UPEC/EAEC hybrid 26.1% (36/138), NMEC/UPEC/DAEC hybrid 18.1% (25/138) and EAEC 15.2% (21/138). Overall most E. coli carried resistance gene to ampicillin 90.6% (125/138), trimethoprim 85.5% (118/138), tetracycline 79.9% (110/138), ciprofloxacin 76.1% (105/138) and 72.5% (100/138) Nalidixic acid. Hybrid pathotypes were more resistant than non-hybrid pathotypes.
Whole genome sequencing reveals the presence of hybrid pathotypes with increased drug resistance among E. coli isolated from regional referral hospitals in Tanzania.
已知大肠杆菌每年导致约200万人死亡,其中腹泻感染最为常见,且通常发生在5岁以下儿童中。尽管非洲是受影响最严重的地区,但关于其致病型多样性和抗菌药物耐药性的信息却很少。
确定坦桑尼亚地区转诊医院患者中分离出的大肠杆菌的致病型多样性和抗菌药物耐药性。
一项基于实验室的回顾性横断面研究,使用Illumina Nextseq550测序平台对2020年至2021年从坦桑尼亚选定的地区转诊医院收集的138株存档大肠杆菌分离株进行测序。在CGE工具中对序列进行分析,以鉴定耐药基因和毒力基因。使用SPSS 20版软件,以频率和比例的形式汇总数据。
在所有138株测序的大肠杆菌分离株中,观察到的最常见致病型毒力基因是肠外致病性大肠杆菌UPEC的fyuA基因,占82.6%(114/138),以及非典型肠致病性大肠杆菌NMEC的irp基因,占81.9%(113/138)。观察到的大多数大肠杆菌致病型由于基因重叠而以杂交形式存在,最常见的致病型是NMEC/UPEC杂交型,占29.7%(41/138);NMEC/UPEC/EAEC杂交型,占26.1%(36/138);NMEC/UPEC/DAEC杂交型,占18.1%(25/138);以及EAEC,占15.2%(21/138)。总体而言,大多数大肠杆菌携带对氨苄西林的耐药基因,占90.6%(125/138);对甲氧苄啶的耐药基因,占85.5%(118/138);对四环素的耐药基因,占79.9%(110/138);对环丙沙星的耐药基因,占76.1%(105/138);对萘啶酸的耐药基因,占72.5%(100/138)。杂交致病型比非杂交致病型的耐药性更强。
全基因组测序揭示了从坦桑尼亚地区转诊医院分离出的大肠杆菌中存在具有更高耐药性的杂交致病型。